Smart "Thrombus": Self-Localizing UCST-Type Microcage.

ACS Macro Lett

Guangdong Provincial Key Laboratory of Optical Information Materials and Technology and Institute of Electronic Paper Displays, South P. R. China Academy of Advanced Optoelectronics, South P. R. China Normal University, Guangzhou 510006, P. R. China.

Published: March 2023

Embolization is often used to block blood supply for controlling the growth of fibroids and malignant tumors, but limited by embolic agents lacking spontaneous targeting and post-treatment removal. So we first adopted nonionic poly(acrylamide--acrylonitrile) with an upper critical solution temperature (UCST) to build up self-localizing microcages by inverse emulsification. The results showed that these UCST-type microcages behaved with the appropriate phase-transition threshold value around 40 °C, and spontaneously underwent an expansion-fusion-fission cycle under the stimulus of mild temperature hyperthermia. Given the simultaneous local release of cargoes, this simple but smart microcage is expected to act as a multifunctional embolic agent for tumorous starving therapy, tumor chemotherapy, and imaging.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsmacrolett.2c00731DOI Listing

Publication Analysis

Top Keywords

smart "thrombus"
4
"thrombus" self-localizing
4
self-localizing ucst-type
4
ucst-type microcage
4
microcage embolization
4
embolization block
4
block blood
4
blood supply
4
supply controlling
4
controlling growth
4

Similar Publications

Biomimetic Nanomotors for Deep Ischemia Penetration and Ferroptosis Inhibition in Neuroprotective Therapy of Ischemic Stroke.

Adv Mater

November 2024

Department of Pharmaceutics, School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery (Ministry of Education), Shanghai, 201203, China.

Article Synopsis
  • * The newly designed biomimetic nanomotor, Pt@LF, enhances drug delivery and targets areas of cerebral ischemia by using properties of apo-lactoferrin and self-propelling motion, allowing it to cross the blood-brain barrier.
  • * Pt@LF not only helps in breaking down blood clots but also reduces inflammation and protects dying neurons, showing promise as a therapeutic solution for ischemic stroke in both lab and animal studies.
View Article and Find Full Text PDF

A New Shear-Stress-Based Point-of-Care Technology for Evaluation of the Hemostatic Pattern in Whole Blood.

Biosensors (Basel)

October 2024

Stem Cell Unit, Department of Research and Advanced Cancer Diagnostic, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy.

The currently available point-of-care hemostasis tests are burdened by criticisms concerning the use of different activators and inhibitors and the lack of dynamic flow. These operating conditions may constitute an impediment to the determination of the patient's hemostatic condition. Hence, the diffusion of these tests in clinical practice is still limited to specific scenarios.

View Article and Find Full Text PDF

Engineered endothelium-mimicking antithrombotic surfaces via combination of nitric oxide-generation with fibrinolysis strategies.

Bioact Mater

January 2025

School of Materials Science and Engineering, Key Lab of Advanced Technology of Materials of Education Ministry, Southwest Jiaotong University, Chengdu, 610031, China.

Thrombosis associated with implants can severely impact therapeutic outcomes and lead to increased morbidity and mortality. Thus, developing blood-contacting materials with superior anticoagulant properties is essential to prevent and mitigate device-related thrombosis. Herein, we propose a novel single-molecule multi-functional strategy for creating blood-compatible surfaces.

View Article and Find Full Text PDF

Cardiac myxoma following transcatheter closure of an atrial septal defect.

Proc (Bayl Univ Med Cent)

May 2024

Kscien Organization for Scientific Research (Middle East office), Kurdistan, Iraq.

Article Synopsis
  • No significant connection has been previously reported between atrial septal defects (ASD) and cardiac myxomas, but this study presents a case of a 56-year-old woman who developed a cardiac myxoma following ASD closure.
  • After experiencing symptoms like dizziness and palpitations three months post-surgery, imaging revealed a large mass in her left atrium, which was later confirmed as an atrial myxoma through surgery and histopathological examination.
  • The case highlights the diagnostic difficulties in differentiating between a benign myxoma and a harmful thrombus, emphasizing that while there's no established link between ASD closure devices and myxoma formation, it remains a possible risk.
View Article and Find Full Text PDF

Hands-on training is a crucial part of education in neuroendovascular treatment to ensure safe and rapid acquisition of techniques. However, there is a significant gap between training and actual clinical practice. This study will introduce innovations for more practical thrombus retrieval training that was developed in this process.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!